GSK598809 is a selective D(3)R antagonist recently progressed in Phase I trials. GSK-598809 may decrease the rewarding effects of contextual cues associated with drug intake preclinically, which may reduce drug craving in humans.
Molekulargewicht:
495.54
CAS Nummer:
[1310803-30-5]
Formel:
C23H25F4N5OS
Target-Kategorie:
Others
T71001
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten